Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Mean diffusivity: a biomarker for CSF-related disease and genetic liability effects in schizophrenia.

Narr KL, Hageman N, Woods RP, Hamilton LS, Clark K, Phillips O, Shattuck DW, Asarnow RF, Toga AW, Nuechterlein KH.

Psychiatry Res. 2009 Jan 30;171(1):20-32. doi: 10.1016/j.pscychresns.2008.03.008.

2.

Mean diffusivity and fractional anisotropy as indicators of disease and genetic liability to schizophrenia.

Clark KA, Nuechterlein KH, Asarnow RF, Hamilton LS, Phillips OR, Hageman NS, Woods RP, Alger JR, Toga AW, Narr KL.

J Psychiatr Res. 2011 Jul;45(7):980-8. doi: 10.1016/j.jpsychires.2011.01.006.

3.

Disease and genetic contributions toward local tissue volume disturbances in schizophrenia: a tensor-based morphometry study.

Yang Y, Nuechterlein KH, Phillips OR, Gutman B, Kurth F, Dinov I, Thompson PM, Asarnow RF, Toga AW, Narr KL.

Hum Brain Mapp. 2012 Sep;33(9):2081-91.

4.

Increased diffusivity in superior temporal gyrus in patients with schizophrenia: a Diffusion Tensor Imaging study.

Lee K, Yoshida T, Kubicki M, Bouix S, Westin CF, Kindlmann G, Niznikiewicz M, Cohen A, McCarley RW, Shenton ME.

Schizophr Res. 2009 Mar;108(1-3):33-40. doi: 10.1016/j.schres.2008.11.024.

5.

Gray and white matter volumetric and diffusion tensor imaging (DTI) analyses in the early stage of first-episode schizophrenia.

Moriya J, Kakeda S, Abe O, Goto N, Yoshimura R, Hori H, Ohnari N, Sato T, Aoki S, Ohtomo K, Nakamura J, Korogi Y.

Schizophr Res. 2010 Feb;116(2-3):196-203. doi: 10.1016/j.schres.2009.10.002.

PMID:
19854618
6.

The contributions of disease and genetic factors towards regional cortical thinning in schizophrenia: the UCLA family study.

Yang Y, Nuechterlein KH, Phillips O, Hamilton LS, Subotnik KL, Asarnow RF, Toga AW, Narr KL.

Schizophr Res. 2010 Nov;123(2-3):116-25. doi: 10.1016/j.schres.2010.08.005.

7.

Association of genetic risks for schizophrenia and bipolar disorder with specific and generic brain structural endophenotypes.

McDonald C, Bullmore ET, Sham PC, Chitnis X, Wickham H, Bramon E, Murray RM.

Arch Gen Psychiatry. 2004 Oct;61(10):974-84.

PMID:
15466670
8.

Regional gray matter, white matter, and cerebrospinal fluid distributions in schizophrenic patients, their siblings, and controls.

Cannon TD, van Erp TG, Huttunen M, Lönnqvist J, Salonen O, Valanne L, Poutanen VP, Standertskjöld-Nordenstam CG, Gur RE, Yan M.

Arch Gen Psychiatry. 1998 Dec;55(12):1084-91.

PMID:
9862551
9.

Regional changes of cortical mean diffusivities with aging after correction of partial volume effects.

Jeon T, Mishra V, Uh J, Weiner M, Hatanpaa KJ, White CL 3rd, Zhao YD, Lu H, Diaz-Arrastia R, Huang H.

Neuroimage. 2012 Sep;62(3):1705-16. doi: 10.1016/j.neuroimage.2012.05.082.

10.

Regional specificity of cerebrospinal fluid abnormalities in first episode schizophrenia.

Narr KL, Bilder RM, Woods RP, Thompson PM, Szeszko P, Robinson D, Ballmaier M, Messenger B, Wang Y, Toga AW.

Psychiatry Res. 2006 Jan 30;146(1):21-33.

PMID:
16386409
11.

Associations between white matter microstructure and amyloid burden in preclinical Alzheimer's disease: A multimodal imaging investigation.

Racine AM, Adluru N, Alexander AL, Christian BT, Okonkwo OC, Oh J, Cleary CA, Birdsill A, Hillmer AT, Murali D, Barnhart TE, Gallagher CL, Carlsson CM, Rowley HA, Dowling NM, Asthana S, Sager MA, Bendlin BB, Johnson SC.

Neuroimage Clin. 2014 Feb 19;4:604-14. doi: 10.1016/j.nicl.2014.02.001.

12.

Positive symptoms and water diffusivity of the prefrontal and temporal cortices in schizophrenia patients: a pilot study.

Park JY, Park HJ, Kim DJ, Kim JJ.

Psychiatry Res. 2014 Oct 30;224(1):49-57. doi: 10.1016/j.pscychresns.2014.07.003.

PMID:
25106804
13.

Fiber tractography reveals disruption of temporal lobe white matter tracts in schizophrenia.

Phillips OR, Nuechterlein KH, Clark KA, Hamilton LS, Asarnow RF, Hageman NS, Toga AW, Narr KL.

Schizophr Res. 2009 Jan;107(1):30-8. doi: 10.1016/j.schres.2008.10.019.

14.

Mapping corticocortical structural integrity in schizophrenia and effects of genetic liability.

Phillips OR, Nuechterlein KH, Asarnow RF, Clark KA, Cabeen R, Yang Y, Woods RP, Toga AW, Narr KL.

Biol Psychiatry. 2011 Oct 1;70(7):680-9. doi: 10.1016/j.biopsych.2011.03.039.

15.

Sulcal thickness as a vulnerability indicator for schizophrenia.

Goghari VM, Rehm K, Carter CS, MacDonald AW.

Br J Psychiatry. 2007 Sep;191:229-33.

16.

Reduced grey and white matter volumes in the temporal lobe of male patients with chronic schizophrenia.

Okugawa G, Sedvall GC, Agartz I.

Eur Arch Psychiatry Clin Neurosci. 2002 Jun;252(3):120-3.

PMID:
12192469
17.

The corpus callosum in schizophrenia-volume and connectivity changes affect specific regions.

Rotarska-Jagiela A, Schönmeyer R, Oertel V, Haenschel C, Vogeley K, Linden DE.

Neuroimage. 2008 Feb 15;39(4):1522-32.

PMID:
18096406
18.

Regionally specific cortical thinning and gray matter abnormalities in the healthy relatives of schizophrenia patients.

Goghari VM, Rehm K, Carter CS, MacDonald AW 3rd.

Cereb Cortex. 2007 Feb;17(2):415-24.

19.

Middle and inferior temporal gyrus gray matter volume abnormalities in first-episode schizophrenia: an MRI study.

Kuroki N, Shenton ME, Salisbury DF, Hirayasu Y, Onitsuka T, Ersner-Hershfield H, Yurgelun-Todd D, Kikinis R, Jolesz FA, McCarley RW.

Am J Psychiatry. 2006 Dec;163(12):2103-10.

20.

A diffusion tensor MRI study of white matter integrity in subjects at high genetic risk of schizophrenia.

Muñoz Maniega S, Lymer GK, Bastin ME, Marjoram D, Job DE, Moorhead TW, Owens DG, Johnstone EC, McIntosh AM, Lawrie SM.

Schizophr Res. 2008 Dec;106(2-3):132-9. doi: 10.1016/j.schres.2008.09.016.

PMID:
18849149
Items per page

Supplemental Content

Support Center